Chronic Low Back Pain and Meditation

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 22, 2022

Study Completion Date

December 22, 2022

Conditions
Pain
Interventions
BEHAVIORAL

Mindfulness

A well-validated brief meditation-based mental training regimen \[four sessions; 20 min/session\] is used to teach patients to independently practice closing their eyes and take a deep breath every few minutes.

DRUG

Naloxone

A 0.15 mg/kg bolus dose of naloxone (Naloxone hydrochloride, Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, California) in 25ml normal saline will be administered over 10 minutes. The investigators also will administer a supplementary IV infusion dose of 0.1mg/kg/hour naloxone immediately after bolus infusion will cease till the end of the experiment.

OTHER

Saline

A 0.15 mg/kg bolus dose of saline in 25ml normal saline will be administered over 10 minutes. The investigators also will administer a supplementary IV infusion dose of 0.1mg/kg/hour saline immediately after bolus infusion will cease till the end of the experiment.

BEHAVIORAL

Meditation

A well-validated brief meditation-based mental training regimen \[four sessions; 20 min/session\] is used to teach patients to independently practice closing their eyes and take a deep breath every few minutes.

Trial Locations (2)

92093

Altman Clinical and Translational Research Institute, La Jolla

92122

UC San Diego Center for Mindfulness, San Diego

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

University of California, San Diego

OTHER

NCT04034004 - Chronic Low Back Pain and Meditation | Biotech Hunter | Biotech Hunter